US Patent 7935825 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
Patent 7935825 was granted and assigned to Allergan on May, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+85 characters)
Article
Patent abstract
According to the invention there is provided a compound the formula I;
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07935825 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain US Patent 7935825 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
Infobox
Patent Number
0793582500
Patent Number
793582500
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079358250
Date of Patent
May 3, 2011
0Patent Application Number
118001650
Date Filed
May 4, 2007
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079358250
Date of Patent
May 3, 2011
0Patent Application Number
118001650
Date Filed
May 4, 2007
0Official Website
Patent Primary Examiner
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07935825 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07935825
Date of patent
May 3, 2011
Patent application number
11800165
Date Filed
May 4, 2007
Patent primary examiner
Find more entities like US Patent 7935825 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
